As my traditional monthly call to the IR, I talked to Clint today. He confirmed that the company is waiting to hear from FDA on Rett trial. It sounded like the time after they get the green light and before they start the trial will be rather short. Both will be announced when they occur. Also they are waiting to hear the approval from the EU authorities on PDD, but he said they are not doing it in Sweden, which was my assumption. He was positive about all three trials. I asked him about in which conference we will get an update about the AD trial, he did not say. But I guess we should get at least three year data some time during the Q3.
Market Data 
Markets 
AI
